SERPINC1 and type 1 diabetes mellitus: In the islet transplantation group, markers of atherothrombotic risk factors were reduced. Notably, there was a significant decrease in F1.2 and XDP levels. Additionally, an improvement in natural anticoagulant activity was observed, as evidenced by increased protein C antigen activity and ATIII levelsPatient survival was significantly higher in the islet transplantation group than T1D patients still on hemodialysis group (p = 0.05)The cardiovascular mortality rate was comparable with 18% in the islet transplantations, and 16% in the T1D patients still on hemodialysis group